Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do?

New tuberculosis (TB) diagnostics are at a crossroads: their development, evaluation, and implementation is severely damaged by resource diversion due to COVID-19. Yet several technologies, especially those with potential for non-invasive non-sputum-based testing, hold promise for efficiently triagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulgader, Shima M., Okunola, Anna O., Ndlangalavu, Gcobisa, Reeve, Byron W.P., Allwood, Brian W., Koegelenberg, Coenraad F.N., Warren, Rob M., Theron, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Thematic Review Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533455/
https://www.ncbi.nlm.nih.gov/pubmed/35760050
http://dx.doi.org/10.1159/000525142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533455/
https://www.ncbi.nlm.nih.gov/pubmed/35760050
http://dx.doi.org/10.1159/000525142

Ejemplares similares